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Abstract Caldendrin is a neuronal calcium-binding protein,
which is highly enriched in the postsynaptic density fraction
and exhibits a prominent somato-dendritic distribution in brain.
Two additional splice variants derive from the caldendrin gene,
which have unrelated N-termini and were previously only de-
tected in the retina. We now show that these isoforms are
present in neurohypophyseal axons and on secretory granules
of endocrine cells. In light of the described interaction of the
Caldendrin C-terminus with Q-type Cav2.1 calcium channels
these data suggest that this interaction takes place in neuro-
hypophyseal axons and pituitary cells indicating functions of
the short splice variants in triggering Ca2+ transients to a vesic-
ular target interaction.
% 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: EF-hand; Immunogold electron microscopy;
Alternative splicing; Hormone release;
Meuronal calcium sensor
1. Introduction
Caldendrin is a calcium-binding protein (CaBP) associated
with the somato-dendritic cytoskeleton of mature neurons
that is particularly enriched in the postsynaptic density
(PSD)[1,2]. Like its closest relative Calmodulin (CaM) Cal-
dendrin contains four EF-hand motifs as high a⁄nity Ca2þ-
binding sites, however, modeling of the EF-hand structure
suggests that Caldendrin’s surface charges exhibit an altered
distribution as compared to CaM [3]. The N-terminal half of
Caldendrin exhibits no similarity to other known proteins [1].
Because of its unique structure, the altered distribution of
surface charges, its tight association with the cortical cytoskel-
eton and its enrichment in the PSD, it is assumed that Cal-
dendrin ful¢lls functions di¡erent from those of hitherto char-
acterized neuronal Ca2þ sensors [1^4].
Interestingly two alternatively spliced isoforms of Calden-
drin also named CaBP1a+b have been identi¢ed recently [2,5].
These isoforms arise by usage of an alternative start codon on
an exon downstream of exon 1 [2] and the insertion of another
alternatively spliced exon downstream of exon 2 (Fig. 1). This
results in the generation of two proteins with N-termini un-
related to Caldendrin, both harboring an N-myristoylation
motif, fused to the C-terminus containing the EF-hand motifs
(Fig. 1). To date, both splice isoforms were detected only at
low levels in retina and sparsely in cerebellum [3,4], question-
ing a major physiological signi¢cance of this splicing event in
brain. In a recent study in human brain we surprisingly found
a prominent granular staining of hypothalamic axons [6]. In
parallel two recent studies suggested that the C-terminal half
of Caldendrin interacts with essential protein components of
Ca2þ-dependent neuronal exocytosis, i.e. the Cav2.1 calcium
channel and the inositol 1,4,5-triphosphate (InsP3) receptor
(InsP3R) [7,8]. At present, however, the interaction with the
P/Q-type calcium channel Cav2.1 is di⁄cult to reconcile with
the prominent somato-dendritic localization of Caldendrin
and its clear absence from presynaptic structures in brain
[1,2]. Therefore this unexpected observation prompted us to
investigate the expression of Caldendrin splice variants in rat
hypothalamus and pituitary in more detail.
2. Materials and methods
Adult Wistar and Lewis rats of both sexes, kept under normal
laboratory conditions, were used for the investigation. Dissected tissue
specimens from rat pituitary were quenched in isopentane precooled
with liquid nitrogen, freeze-dried for 48 h and ¢xed by vapor-phase
formaldehyde. Following embedding of the specimens in epoxy resin
(Araldite), serial semithin sections were cut and processed for immu-
nohistochemical staining. Sections were incubated with caldendrin-
antibody [1,2] (at dilutions between 1:300 and 1:1000) in phos-
phate-bu¡ered saline containing 0.1% Triton X-100 for 24 h at 4‡C,
followed by incubation for 30 min at room temperature with the
second antibody, biotin-labeled goat anti-rabbit IgG (Jackson Immu-
no Research, West Grove, USA). The sections were then incubated
for 30 min with a preformed complex of biotin-peroxidase/strepta-
vidin (Jackson Immuno Research), and peroxidase activity was re-
vealed using 0.02% diaminobenzidine hydrochloride with 0.3% nickel
sulfate as chromogen. Embedding of tissue specimens was performed
as outlined elsewhere [9,10].
Reverse transcription-polymerase chain reaction (RT-PCR), West-
ern blot analysis and hypothalamic immunostainings were done as
described previously [1,2]. Immunocytochemical procedures were per-
formed according to the standard DAB/Ni immunoperoxidase tech-
nique [2]. Double immunolabeling for Caldendrin and phosphorylated
neuro¢lament as an axonal marker was done with a monoclonal anti-
body (SMI312, Sternberger, 1:4000).
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For fractionation experiments pituitary glands of 10 animals (week
7^16) were dissected and stored at 380‡C. Tissue homogenization was
done in 0.32 M Sucrose, 5 mM HEPES pH 7.4, and proteinase in-
hibitor cocktail (Complete/Roche). After removal of nuclei and cell
debris P2 (crude membranes) was prepared (15 min 12 000Ug). P2
pellets were extracted with 0.1% Triton X-100 in 20 mM HEPES pH
7.4 for 30 min on ice. Centrifugation for 30 min at 12 000Ug resulted
in a Triton-soluble and -insoluble fraction.
3. Results
Utilizing an antibody directed against the common C-ter-
minal part of Caldendrin, detecting all splice variants [2], we
could identify two immunoreactive bands in hypothalamic
protein homogenates (Fig. 2a). The band at 28 kDa most
likely represents the Caldendrin splice isoform Caldendrin-
S2 [2], whereas the doublet at 33/36 kDa corresponds to the
two protein products of the long Caldendrin isoform (Calden-
drin-L) that most likely di¡er in their phosphorylation status
[1]. In comparison to protein homogenates from cortex Cal-
dendrin immunoreactivity is clearly less prominent in the hy-
pothalamus and the ratio of bands shows a relatively higher
abundance of the 28 kDa isoform (Fig. 2a). Interestingly, in
pituitary tissue we found almost exclusively immunoreactivity
of Caldendrin-S1, the 25 kDa isoform, and to a lesser extent
of Caldendrin-S2, the 28 kDa isoform (Fig. 2a). Dissection of
the pituitary into the anterior/intermediate and the neural lobe
revealed the presence of Caldendrin-S1 and -S2 in neural lobe
protein homogenates at similar levels, indicating that alterna-
tive splicing of the Caldendrin RNA is uniquely regulated in
the hypothalamic-hypophyseal system. Thus, expression of the
long isoform seems to be restricted to neurons, whereas Cal-
dendrin-S1 and -S2 in addition are found in endocrine tissue
and Caldendrin-S1 seems to be the major isoform expressed in
endocrine cells of the adenohypophysis (Fig. 2a).
As previously reported in humans [6] subsequent immunos-
tainings of rat hypothalamic tissue sections revealed a somato-
dendritic (not shown) as well as an axonal localization of
Caldendrin throughout the hypothalamus (Fig. 3a). Strong
immunolabeling on axons, which had frequently the appear-
ance of Hering-bodies, vesicular structures known to contain
hypothalamic releasing hormones, was observed in the lateral
hypothalamus (Fig. 3a,b). Immunolabel of the median emi-
nence was very faint (not shown), suggesting that mainly ax-
ons descending from the supraoptic and paraventricular nu-
cleus to the neurohypophysis are Caldendrin immunopositive.
The antibody used in this study does not allow di¡erentia-
tion between splice isoforms in imunostained sections. We
therefore determined by transcript analysis whether the axonal
and putative vesicular immunolabel is due to an association of
speci¢c Caldendrin isoforms with these structures. RT-PCR
with hypothalamic and pituitary tissue revealed a di¡erential
expression of mRNA for the three splice isoforms (Fig. 4). In
accordance with the immunoblot data, Caldendrin-L and -S2
transcripts were found to be present in the hypothalamus
(Fig. 4), whereas Caldendrin-S1 was only detected at low lev-
els (Fig. 4). No PCR product for Caldendrin-L, however, was
present after reverse transcription of pituitary RNA, whereas
intense bands were seen for Caldendrin-S1 and -S2 (Fig. 4).
These results suggest the localization of Caldendrin-S1 and
-S2 in axons most likely descending from the hypothalamus.
Accordingly, we observed in the pituitary punctate immuno-
reactivity in nerve terminals of the neural lobe (Fig. 5). In
addition, strong immunoreactivity was detectable in all endo-
crine cells of the intermediate (Fig. 5) and many Caldendrin-
immunoreactive cells were identi¢ed throughout the anterior
lobe (Fig. 5). Colocalization studies of serial semithin sections
demonstrated that from all endocrine cell types somatotrophs
were most densely stained (Fig. 5), whereas lactotrophs and
thyrotrophs were only faintly immunopositive or entirely non-
reactive. Caldendrin immunostaining in endocrine cells was
mainly cytoplasmic and obviously paralleled the distribution
of secretory granules (Fig. 5). Moreover, immunogold elec-
tron microscopy (EM) provided direct evidence that gold par-
ticles predominantly labeled secretory granules in hypophyseal
Fig. 1. Alternative splicing generates three Caldendrin splice iso-
forms di¡ering in their N-terminal sequence. Depicted is a schematic
representation of the three Caldendrin splice isoforms. Exons are
depicted as numbered boxes. In contrast to the long isoform, Cal-
dendrin-S1 and -S2 arise from two separate exons downstream of
exon 1. Exon 2 harbors an independent start codon, which can lead
to the generation of two shorter isoforms containing or lacking
exon 3. The N-terminus of the resulting proteins is unrelated to Cal-
dendrin and shows a putative N-myristoylation site. Exon 4 to exon
8 are common for all Caldendrin isoforms and encode the four
Ca2þ binding EF-hands starting with EF-hand No. 1 on exon 5,
No. 2 on exon 6 and No. 3 and No. 4 on exon 7.
Fig. 2. Western Blot analysis of pituitary, hypothalamus and cortex.
Protein content was determined and same amounts loaded per lane
(30Wg). a: Protein homogenates from cortex (Cx), hypothalamus
(Ht), adenohypophysis (Ah) and neurohypophysis (Nh) exhibit a
di¡erent pattern of immunoreactive bands. Whereas the 33/36 kDa
doublet (Caldendrin-L) is prominent in cortex, the ratio of the 28
kDa isoform (Caldendrin-S2) relative to the abundance of the larger
bands is increased. In pituitary the 33/36 kDa bands are virtually
absent but the 28 kDa and especially the 25 kDa isoform (Calden-
drin-S1) are prominently present. b: Whereas the 28 kDa immuno-
reactive band is almost exclusively in the soluble fraction (S2) after
subcellular fractionation of pituitary protein homogenates, the 25
kDa isoform is associated with the particulate fraction (P23). Inter-
estingly a large proportion of this immunoreactivity is releasable in
the presence of 0.1% Triton X-100 (P2+), indicating an association
with membraneous protein compartments.
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endocrine cells in the adenohypophysis and to a markedly
lesser extent neurosecretory granules in nerve terminals of
the neural lobe (Fig. 5). Unfortunately, immunogold EM of
hypothalamic tissue did not lead to conclusive results.
To further substantiate a vesicular association of the short
Caldendrin isoforms we analyzed their behavior in compari-
son to the long isoform after subcellular fractionation and
subsequent Triton X-100 extraction of P2 pituitary tissue ho-
mogenates. Previous work in brain has shown that Calden-
drin-L is only extractable from the insoluble P2 protein frac-
tion under very harsh conditions, suggesting a very tight
association with cytoskeletal but not membraneous brain pro-
tein components [1,2]. In contrast Caldendrin-S1 is mainly
present in the insoluble P2 fraction and Triton X-100 extrac-
tion of this protein preparation leads to a substantial release
of this isoform (Fig. 2b), suggestive of an association with
membraneous but not cytoskeletal elements. Similarly, Cal-
dendrin-S2, which is less abundant in the pituitary and seems
to be more soluble than Caldendrin-S1, could be released
from the insoluble P2 protein pool among detergent treatment
(Fig. 2b).
4. Discussion
Despite close sequence similarities neuronal calcium sensor
(NCS) proteins are suggested to have di¡erent functions,
which include roles in the modulation of neurotransmitter
release and the direct regulation of ion channels [11,12]. In
the present study compelling evidence was provided that the
Caldendrin low molecular weight isoforms are associated with
vesicles and secretory granules and are present in axons of
hypothalamic neuroendocrine cells. Previous studies have
shown that somato-dendritic Caldendrin-L immunoreactivity
is prominent in brain regions with a laminar organization [2],
indicating a striking dichotomy in the cellular localization of
the short and long Caldendrin splice variants. This suggests
that either a di¡erent promoter or a yet unknown di¡eren-
tially expressed splicing factor might regulate the splicing
event in the corresponding cell types. It should be noted,
however, that Caldendrin-L is also expressed in testicular tis-
sue where it is localized to the specialized acrosomal cytoskel-
eton [13].
The function of the short Caldendrin isoforms at secretory
granules is at present not yet clear. Interestingly, however,
secretory granules in endocrine cells are considered as InsP3-
sensitive Ca2þ stores [14] and Caldendrin/CaBP1 has recently
been shown to act as a ligand of InsP3 receptors [8] in a Ca2þ/
CaM-independent manner. Notably, a prominent component
of secretory granules, chromogranin A, has been shown to
modulate InsP3 receptor channel activity of the granule mem-
brane and may thus be involved in the control of intracellular
Ca2þ concentration [15]. Moreover, the short splice isoforms
harbor a N-myristoylation motif, which could provide a
means by which they can be anchored to vesicular mem-
branes. Additionally, it was recently reported that Calden-
drin/CaBP1 interacts with Cav2.1 channels, a group of P/Q-
type voltage-dependent Ca2þ channels which are presumably
localized presynaptically and involved in neurotransmitter re-
lease [7]. As already mentioned above this is at variance with
the somato-dendritic localization of the long Caldendrin iso-
form and the very low abundance of the shorter splice var-
iants in brain. Previous studies on acutely dissociated nerve
endings of rat neurohypophyses, however, have shown that
P/Q-type Ca2þ channels are present on a subset of neurohy-
pophysial terminals where, in combination with N- and
L-channels, they control arginine vasopressin but not oxyto-
cin peptide neurosecretion [16]. Furthermore it was demon-
strated that peptide hormone secretion from neurohypophy-
seal nerve endings requires activation of L-type Ca2þ channels
[16,17]. This is quite di¡erent from the role of Ca2þ channels
in classical neurotransmission, in which the N- and P/Q-type,
rather than L-type Ca2þ-channel currents dominate the con-
trol of neurotransmitter release [18]. It is therefore an attrac-
tive hypothesis resulting from our ¢ndings that the short Cal-
dendrin splice isoforms might be selectively involved in the
regulation of arginine-vasopressin release in the neural lobe,
which seems to require Q-type Ca2þ channels. Thus the secre-
tion of peptide hormones in the neuroendocrine system might
have Ca2þ-signaling requirements di¡erent from those of syn-
aptic neurotransmitter release, which might explain the vesic-
Fig. 3. Frontal sections depicting Caldendrin immunoreactivity in the rat hypothalamus. a,b: Caldendrin-immunopositive axons could be de-
tected in the lateral hypothalamic area (see arrows). c,d: Double immunolabelling with an antibody directed against phosphorylated neuro¢la-
ment (d) showed that Caldendrin-immunopositive (c) ¢bers are axons. These axons frequently exhibited Hering-body-like blebs which are
known to consist of large dense core vesicles containing polypeptide-releasing hormones (see arrows). Interestingly, these blebs were frequently
colocalized with Caldendrin immunoreactivity. Scale bar is 50 Wm.
Fig. 4. RT-PCR from mRNA extracted from cortex (Cx), hypothal-
amus (Ht), adeno- (Ah) and neurohypophysis (Nh). Whereas tran-
script of Caldendrin-L (b; 900 bp) is largely restricted to neural tis-
sue, Caldendrin-S2 transcripts (a; 700 bp) are found in neural as
well as endocrine tissue. Caldendrin-S1 mRNA (a; 500 bp), how-
ever, is particularly abundant in the adeno- and neurohypophysis.
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ular localization of the short Caldendrin splice isoforms. To-
gether our ¢ndings demonstrate that alternative splicing of
Caldendrin can generate isoforms with a di¡erent cellular lo-
calization and most likely di¡erent functions in the transduc-
tion of Ca2þ signals. Interestingly, the primary structure of
short Caldendrin isoforms is similar to those of other NCS
proteins, in that they harbor a short N-terminal segment with
a myristoylation motif in front of the four EF-hands, which
might have arisen by duplication of the calmodulin gene [12].
We therefore speculate that in contrast to Caldendrin-S1 and -
S2, Caldendrin-L has evolved with uncommon requirements
for somato-dendritic Ca2þ signaling of mainly limbic and cor-
tical neurons, whereas the short variants are more closely
related to classical NCS proteins.
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Fig. 5. Immunohistochemical localization of Caldendrin in the pituitary. Semithin sections of the pituitary gland (A) show punctate Caldendrin
immunoreactivity in the neural lobe (NL), densely immunostained endocrine cells in the intermediate lobe (IL), and variable degrees of immu-
noreactivity in the anterior lobe (AL). B: Two adjacent sections of the anterior lobe reveal that Caldendrin-positive cells largely correspond to
growth hormone-positive somatotrophs (C; arrows point to identical groups of cells in both sections). Subplasmalemmal immunoreactivity is
evident in anterior lobe cells immunostained for either Caldendrin (D) or corticotropin (E; arrows point to identical cells in both sections). Im-
munogold labelling of hypophyseal neural lobe (F) and intermediate lobe (G). Gold particles indicating Caldendrin immunoreactivity are associ-
ated with secretory granules. N=nucleus. Bars = 20 Wm in A^E and 200 nm in F^G.
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